Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2023-09-26 Investor Presentation
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a scheduled meeting between company officials and analysts/institutional investors. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is short (2219 characters) and serves as an announcement of the upcoming investor meeting and the availability of the presentation, rather than containing the presentation or detailed financial data itself. Therefore, it is best classified as an Investor Presentation announcement. Given the content and context, the appropriate filing type is Investor Presentation (IP).
2023-09-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a short announcement dated September 20, 2023, informing stock exchanges about scheduled meetings with analysts and institutional investors on specific future dates. It references the SEBI Listing Obligations and Disclosure Requirements, 2015, and mentions that the Investor Presentation has been uploaded on the company's website and stock exchanges. The document does not contain any financial data or detailed report content itself but rather informs about the schedule of investor meetings and the availability of the presentation elsewhere. The document length is only 2245 characters, which is quite short and fits the pattern of an announcement rather than a full report. Therefore, this document is best classified as an Investor Presentation (IP) announcement or related notice. However, since the document itself is not the presentation but an announcement of the schedule and availability of the presentation, it aligns with the Investor Presentation (IP) category as it focuses on investor communication and presentation scheduling.
2023-09-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a scheduled meeting with analysts and institutional investors. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is short (2225 characters) and serves as an announcement of the meeting and the availability of the presentation, rather than containing the presentation itself or detailed financial data. It is a regulatory announcement under SEBI Listing Regulations about investor meetings and presentation availability. Therefore, it fits best under Investor Presentation (IP) category as it relates to investor communication and presentation scheduling.
2023-09-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a short announcement dated September 13, 2023, informing stock exchanges about a scheduled analyst/institutional investor meeting on September 20, 2023. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is brief (2222 characters) and serves to notify about the meeting and the availability of the presentation rather than containing the presentation or detailed financial data itself. According to the 'MENU VS MEAL' rule, such a short notice about an upcoming investor meeting and reference to an uploaded presentation fits the category of an Investor Presentation announcement rather than the presentation document itself. Therefore, the appropriate classification is Investor Presentation (IP).
2023-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated September 11, 2023, informing stock exchanges about a scheduled Analyst/Institutional Investor meeting on September 15, 2023. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is primarily an announcement of the schedule of investor meetings and the availability of the presentation, not the presentation itself. The length is only 2225 characters, which is short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this document should be classified as an Investor Presentation announcement, but since it is not the presentation itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings and presentation availability.
2023-09-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated September 8, 2023, informing stock exchanges about a scheduled analyst/institutional investor meeting on September 14, 2023. It references the uploading of an Investor Presentation on the company's website and stock exchanges but does not contain the presentation itself or any financial data. The document is submitted pursuant to SEBI Listing Regulations as a disclosure of the meeting schedule and availability of the presentation. Given the short length (2222 characters) and the nature of the content (announcement of a meeting and reference to an investor presentation), this fits the category of an Investor Presentation announcement rather than the presentation itself. However, since the actual presentation is not included, and this is a notice about the meeting and presentation availability, the best classification is Regulatory Filings (RNS) as a general regulatory announcement. It is not a full investor presentation document, nor a financial report or earnings release. Therefore, the filing type code is RNS with high confidence.
2023-09-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.